The Biomedical Scientist Live
is back for 2024!
ON DEMAND IS NOW AVAILABLE CLICK BELOW TO REGISTER AND WATCH
The Biomedical Scientist Live
About The Biomedical Scientist Live
The Biomedical Scientist Live is back!
The virtual event, brought to you by the Institute of Biomedical Science (IBMS), is available to view on demand now. You can watch a packed line-up of speakers discussing the most timely and vital issues that our profession faces.
The Biomedical Scientist Live event is free to access for IBMS members.
Please contact [email protected] if you have any questions about this event
Programme
Day 1 Programme
Synopsis: Manjinder is a leader, entrepreneur and winner of an Asian Woman of Achievement Award for Science. In this talk she discusses her achievements in the NHS and private sector, her approach to leadership and how to inspire colleagues and teams.
Time: 14.30pm
Speaker: Manjinder Virk
Synopsis: Jonathan and his team recently won an IBMS Award for “Best Use of Research, Innovation or Technology” for a pioneering pilot study to assess the safety and viability of transporting clinical blood products for transfusion via drone. Jonathan will discuss the challenges overcome in the project and the future of transporting by drone.
Time: 14.55pm
Speaker: Jonathan Boxshall
Synopsis: Alice will be speaking about the journey to improve the blood culture pathway at Winchester. Winchester is a spoke site with limited microbiology services, so Alice will talk through the changes they have made, and are in the process of implementing, to ensure patients’ blood culture samples are incubated and managed as quickly as possible.
Time: 15.20pm
Speaker: Alice Goring
Synopsis: Now that most of the ISO 15189 transition assessments have been completed, Alyson will look back over the work that has been done and look forward to UKAS’ future plans.
Time: 15.45pm
Speaker: Alyson Bryant
Synopsis:This session addresses the challenges pathology laboratories face using traditional systems by building practical solutions, such as predictive stock control and integrated lot validation. We delve into the journey of developing an optimal inventory system with industry expertise.This session is a collaborative platform where professionals share their knowledge and experience to tackle common inefficiencies in laboratory workflows. Benefit from decades of biomedical experience as the speakers provide educational insights into inventory optimisation, predictive stock level management and increased operational efficiency, making you feel part of a community striving for excellence.
Time: 16.10pm
Speakers: Andrea Rhodes, Nigel Coles
Synopsis: One of Nicki’s biggest joys is sharing interesting morphology cases with the lab team and post-graduate students. Bitesize Morphology was created during the COVID pandemic as a way to deliver online training to the wider haematology team across her pathology network, and has continued ever since. Here she brings a special episode of Bitesize Morphology to the Biomedical Scientist Live.
Time: 16.35pm
Speaker: Nicki Lawrence
Day 2 Programme
Synopsis: Chris uses a recent cover feature he wrote for The Biomedical Scientist magazine as a launchpad for a fascinating talk on previous pandemics, the potential threat of avian influenza and what else could potentially cause the next pandemic.
Time: 14.30pm
Speaker: Christopher Ring
Synopsis: AI in diagnostics promises to improve lab operations, but challenges remain. This session covers CrelioHealth’s AI journey, practical use cases in diagnostics and patient care, and the hurdles preventing full AI adoption in healthcare. We explore AI as a tool that complements human expertise, not one that replaces it.
Time: 14.55pm
Speaker: Husain Rampurawala, Surabhi Khare
Synopsis: Every year Serious Hazards of Transfusion – the UK’s independent, professionally led haemovigilance scheme – releases a report analysing anonymised information on adverse events and reactions in blood transfusion. In this session Vera, Nikki and Victoria look at the latest report and discuss the key themes and takeaway messages.
Time: 15.20pm
Speakers: Vera Rosa, Nikki Swarbrick, Victoria Tuckley
Synopsis: Why test for group B strep (GBS) infection? A look at the current practice and challenges, an introduction to molecular testing for GBS and an overview of real-world data using a molecular GBS assay and its application.
Time: 15.45pm
Speakers: Douglas Kirkwood
Synopsis: Pathology services in Dorset have been through significant transformations, including the new-build pathology hub on the Bournemouth site. Director for One Dorset Pathology Stephen Harding talks us through the journey.
Time: 16.10pm
Speaker: Stephen Harding
Synopsis: A look at the current global threat of latent TB infection, the immune response to TB, an introduction to IGRA technology, diagnosing TB in the immunosuppressed and an overview of ELISPOT technology and the T-SPOT.TB test. This will be followed by a walk-through of the suite automation solutions that simplify Revvity’s ELISPOT, the T-SPOT.TB test and the benefits that they bring to the test’s workflow.
Time: 16.35pm
Speakers: Tom Jackson-Soutter, Yasmin Malik
Synopsis: The Big Question is a regular feature in The Biomedical Scientist magazine, where we put a timely question to three experts. Here the features makes its way off the page and into a live session, with our panel asked five vital questions on sustainability.
Time: 17.00pm
Speakers: Sheri Scott, Claire Atkinson, Leah Riley
The
Speakers
Jonathan Boxshall
Pathology Quality Manager and Deputy Clinical Pathology Lead
Northumbria Healthcare NHS Foundation Trust
Nicki Lawrence
Principal Biomedical Scientist and Advanced Practitioner in Morphology
Royal Stoke University Hospital
Nicola Swarbrick
Laboratory Incident Specialist
Serious Hazards of Transfusion (SHOT)
Victoria Tuckley
Laboratory Incident Specialist
Serious Hazards of Transfusion (SHOT)
Journal Development Manager, British Journal of Biomedical Science.
Sponsors
Biomedical Data Solutions
Biomedical Data Solutions is a dedicated software house specializing in the provision of laboratory software and data management systems for the diagnostic and blood testing industry worldwide. Established in 1983 as Sanguin International, Biomedical Data Solutions has nearly four decades experience developing software for the donor center and blood bank arena. As such, we have a core competence in providing customized software solutions to meet specific operational needs within high volume donor screening laboratories. Aurora is the core of Biomedical Data Solutions product portfolio and is easy-to use with a broad range of functionality, e.g. Interfacing laboratory analyzers, acting as a complete laboratory information system, or even as a cost-effective LIS "light" solution.
BioMérieux
For 60 years bioMérieux has been providing clinical laboratories with a unique and comprehensive range of integrated diagnostic solutions to address the challenges on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis, and respiratory infections.
Our high medical value diagnostic solutions enable timely detection and identification of pathogens and provide actionable insights that can optimise antibiotic therapy and improve patient outcomes.
Discover how we are continuing to innovate and design diagnostic systems and tests that meet today’s and tomorrow’s health challenges.
CrelioHealth
Problems can be solved the easy way or the right way. At CrelioHealth, we pride ourselves on solving problems the right way. For healthcare providers, we offer more than just remote work; we provide tools for improved efficiency and patient-focused care. Our analytics, charts, and statistics help visualize finances and operations while maintaining the focus on the patient. For patients, we help you manage your medical records with ease. Our understanding of healthcare and analytics enables us to help you manage your health more effectively. Choose CrelioHealth for innovative and streamlined healthcare solutions.
Hologic
Our goal is to minimize doubt and maximize the confidence our customers and their patients have in their decisions and diagnoses. Because when their health is in question, nothing is more important than being sure.
Oxford Immunotec
Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio. In May, Revvity launched as a science-based solutions company focused on developing technologies and solutions across disease pathways to help solve the world’s greatest health challenges.
Oxford Immunotec is a global, high-growth diagnostics company. We bring energy and invention to a world in need of diagnostic truth. We are uniquely placed as the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. Our leading product, the T-SPOT.TB test, is used for diagnosing infection with Tuberculosis, the world’s largest cause of death from infectious disease. The Company is an experienced manufacturer of IVD tests, operating under a fully audited Quality Management System, ensuring rigorous batch control. The company has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA.
Sponsors
Sponsorship and content/speaking opportunities are available for industry suppliers to raise their profile and share their expertise with a large audience of IBMS members and other biomedical scientists.
IBMS Company members receive a 5% discount on all packages. If you’re interested in receiving the sponsorship and content opportunities brochure please complete the below form.
Contact us
To contact us regarding this event:
Email: [email protected]
The Biomedical Scientist magazine and The Biomedical Scientist Live are produced for the IBMS by Redactive.
© 2024